News

We are pleased to announce that the journal Hepatoma Research (ISSN / E-ISSN: 2394-5079 / 2454-2520; Publisher: OAE Publishing Inc. ) has been accepted for inclusion in Scopus by the Content Selection & Advisory Board (CSAB) after a rigorous evaluation on August 7, 2021.

The international webinar "Minimally Invasive Surgery for HCC", chaired by Prof. Ho-Seong Han the President of the Korean Society of Traumatology, from Seoul National University Bundang Hospital, Seoul National University College of Medicine, was successfully held on July 21, 2021.

The webinar "Research on the Risk Factors of Liver Cirrhosis Complicated with HCC" was successfully held on May 31, 2021 by the Editorial Office of Hepatoma Research.

The first Editorial Board Webinar of Hepatoma Research, chaired by our Editor-in-Chief Prof. Guang-Wen Cao from China and Executive Chief Editor Prof. Giuliano Ramadori from Germany, was successfully held on March 24, 2021.

A rigorous and impartial peer-review process is very essential for the success of a journal. We would like to sincerely thank each and every reviewer who dedicated his or her time and expertise to reviewing more than three manuscripts for Hepatoma Research in 2020.

We warmly welcome Prof. Giuliano Ramadori from Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany, an outstanding senior scholar to serve as the Executive Chief Editor to support the journal development.

We warmly welcome two outstanding young scholars of Prof. Allan Tsung, from The Ohio State University Wexner Medical Center, Columbus, United States and Prof. James Fung, from the University of Hong Kong, State Key Laboratory of Liver Research, Hong Kong, China, to take on the role of Associate Editor to support the journal development.

On 2 February 2021, we were so honored and delighted to have a special interview with Professor Isabel Fabregat.

An international seminar on “Systemic Therapy for Cholangiocarcinoma” was successfully held online on 18 December 2020 by the Editorial Office of Hepatoma Research.

On 27 November 2020, we had a special interview with Prof. Guangwen Cao, the Editor-in-Chief of Hepatoma Research.

Hepatoma Research is about to establish a new platform for listening to thoughts from scholars. Scientists need to have a channel to express their ideas in another way, not just limited to publishing papers.

For providing a platform for young scholars with innovative thinking and active academic exchanges to communicate with each other and conduct academic communication with influential experts in liver cancer field, and cultivating candidates for Editorial Board, Hepatoma Research journal plans to set up an Editorial Board with young members and recruit talents worldwide now.

On 20 January 2020, Hepatoma Research's (HR) Annual Meeting of the was held in Xi'an, China. The report on the development of the journal over the past year was given by the HR Editorial Office, which reads as follows.

Editorial Office of Hepatoma Research wish every reader and author a happy new year! We will continuously provide the best service for all of you!

The Fourth Editorial Board Meeting of the journal Hepatoma Research (HR) was successfully held in Wuhan City, China on 8th December 2019, sponsored by 2019 Chinese Academic Conference on Tumor Biomarker (CCTB) and the 13th Youth Scientists Forum on Tumor Biomarker.

We are pleased to announce that Hepatoma Research Journal is now becoming a member of the Committee on Publication Ethics (COPE).

On January 15, 2019, the Annual Report meeting of the Hepatoma Research was held in Xi’an, China. The report on the development of the journal over the past year was given by HR Editorial Office, which reads as follows.

The Third Editorial Board Meeting of the journal Hepatoma Research (HR) was held in Xi’an on September 22rd, where the participants discussed in particular the future development of the journal and the current popular topics in liver cancer.

Since its inauguration in April 2015, Hepatoma Research (HR) has constantly adhered to the concept of high quality publishing and has continued to develop. It has made numerous advancements in 2017 and gained recognition from more experts in the field of liver cancer research. The world has heard our voice.

The second summit forum and the 2017 second Editorial Board meeting of were held on November 25, 2017, in the beautiful city of Nanning, Guangxi Province, China.

A summit forum and the 2017 First Editorial Board meeting of the journal, Hepatoma Research, were held on July 16, 2017, in the beautiful city of Rongcheng, Shandong Province, China. This Editorial Board meeting was the second Editorial Board Meeting to be held in the journal's history, the first being in New Orleans, in the USA in April 2016.

In June, 2017, Hepatoma Research (HR) enters a new era with the change of its Editor-in-Chief (EIC). After two years as the EIC of HR, Prof. Joseph. F. Buell stepped back and was appointed as the honorary EIC of the journal by OAE Publishing Inc.. Former associate editor, Prof. Guang-Wen Cao, was elected as the new EIC with a term of two years.

From February 15-19, 2017, the twenty-sixth annual meeting of the Asian Pacific Association for the Study of the Liver (APASL) was held at the Shanghai International Convention Center in China. Lisa Huang, the Managing Editor of Hepatoma Research (HR) and Assistant Editors Coco Kou and Bonnie Wang attended the meeting to promote the Journal.

On January 10, 2017, 2016 Annual Report meeting of the Hepatoma Research was held. The Managing Editor of Hepatoma Research, Lisa Huang, presented an overall review of the development of the Journal over the past year to all members of the editorial office. A summary of the key events of what has been a very busy year follows.

On December 12, 2016, Fan Min, General Manager of OAE Publishing Company; Yu Dandan, Head of Publishing Department of Hepatoma Research; and Lisa Huang, managing editor of Hepatoma Research, visited Prof. Shu-kui Qin, Honorary Editor of Hepatoma Research and Vice-chairman of Chinese Society of Clinical Oncology (CSCO) at Nanjing Bayi Hospital. They indulged in an in-depth exchange of issues regarding the development of the journal.

On September 23, 2016, the editorial team of Hepatoma Research (Hepatoma Res, HR) visited Prof. Shu-Kui Qin, Chairman of the Chinese Society of Clinical Oncology (CSCO) and member of the American Society of Clinical Oncology (ASCO) in Xiamen, China.

The 19th National Clinical Oncology Congress & Chinese Society of Clinical Oncology (CSCO) was held from September 21-25, 2016, in Xiamen, China. As the premier event of clinical oncology, the CSCO meeting attracted more than 20,000 domestic representatives and more than 150 enterprises and institutions and academic organizations related to oncology.

The 16th Biennial Congress of the Metastasis Research Society (MRS) & the 12th National Congress of the Chinese Society of Tumor Metastasis was held on September 15, 2016, in Chengdu, China.

In accordance with the AACR Annual Meeting 2016, Hepatoma Research (HR) held its very initial Editorial Board meeting on April 17, 2016 at the Antoine’s Restaurant located at Wendy Chatelain, Derrick Roberts, 713 St. New Orleans, Louisiana, USA.

Prof. Joseph F. Buell from Tulane University School of Medicine visited the Innovation Medicine Network for a three-day academic visit and exchange from November 15 to 17, 2015. Mr. Min Fan, Director of the Innovation Investment Group, led the medical editors giving Prof. Buell a warm welcome and reception, and indulged in an in-depth discussion on international medical academic publishing services.